Glancy prongay & murray llp, a leading securities fraud law firm, announces investigation of y-mabs therapeutics, inc. (ymab) on behalf of investors

Los angeles--( business wire )--glancy prongay & murray llp (“gpm”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of y-mabs therapeutics, inc. (“y-mabs” or the “company”) (nasdaq: ymab) investors concerning the company's possible violations of the federal securities laws.
YMAB Ratings Summary
YMAB Quant Ranking